FDA Determines Regulatory Review Period for ORGAN CARE SYSTEM HEART Patent Extension

Summary

The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for the patent extension of ORGAN CARE SYSTEM HEART (OCS HEART SYSTEM), a medical device, following a submission to the US Patent and Trademark Office (USPTO).